Akamai Technologies posted its strongest single-day price move in years on May 7 and 8, and the story this week is about a 12% short position now sitting on a 42% paper loss.
The earnings result was the catalyst. Akamai's Q1 print triggered a 21% gap on May 7, driving the stock to $147.71 by Friday — a 42% gain on the week. That move compressed what had been a meaningful short base, with SI running near 12% of free float for most of April. Shorts who built in mid-April around the 12.5–12.8% range were caught cleanly offside.
The short position has barely moved despite the price shock, which is the key tension entering next week. Short interest dipped only marginally, from 12.1% to 11.95% of free float between May 1 and May 7. That's a ~1.7% week-on-week rise in share count rather than a meaningful cover. Shorts are staying put, at least for now. The borrow market gives them little reason to flee — cost to borrow has fallen 9% this week to a comfortable 0.49%, and availability remains loose. The short score at 55.9 sits in moderate territory, down from a local peak above 56.5 earlier in the week, suggesting the pressure on the position has eased at the margin but has not resolved.
Options confirm the dominant mood is bullish, not defensive. The put/call ratio at 0.55 is near the top of this week's range but only slightly above its 20-day average of 0.52, with a z-score of 0.59. That's nowhere near the defensive positioning you'd expect if traders were bracing for a reversal. The 52-week low on PCR is 0.42 — the market is well inside that range and tilting toward calls.
Analysts scrambled to catch up after the gap. Seven firms raised targets on May 8 alone — the day after the print. The moves were aggressive: Keybanc went to $195 from $120, Guggenheim to $181 from $133, Scotiabank to $180 from $120, and Evercore ISI to $165 from $130 while holding an Outperform. The mean target of $143.76 is now fractionally below the current price of $147.71, which frames the debate neatly: the Street just repriced the company upward in one session and the stock has already run through the new consensus midpoint. Firms holding Neutral or Sector Perform ratings — UBS, RBC, Piper Sandler — raised targets but kept cautious ratings, pointing to a Street that sees the story as real but isn't yet willing to chase it at $148. The bull case centres on the Edgio acquisition and the AI/cloud pivot; the bear case remains that CDN margin pressure persists and cloud investments weigh on near-term cash flow.
Institutional holders add useful context. First Trust added 957,000 shares in April, Dimensional added 784,000, and BNY Asset Management added 820,000 — all reported as of April 30, before the gap. Those positions are now significantly in the money. Vanguard and BlackRock hold 12.5% and 7.2% respectively and have been slowly adding, providing a stable floor. Insider activity through mid-March ran net negative, with the CFO and COO selling in March at prices around $101–$108 — well below Friday's close. Those sales look like routine scheduled activity, but the contrast with the current price is notable.
Peer performance fractures the picture. DOCN is up 59% on the week — a comparison name that caught its own catalyst — while FSLY fell 27%. NET shed 24% on Friday alone. The divergence within Akamai's peer group suggests idiosyncratic earnings reactions are dominating sector trends, rather than any macro tailwind lifting the space broadly.
The setup for the confirmed May 13 event (flagged in the data as a next calendar entry) is whether the short base of nearly 12% stays disciplined or begins to cover into further strength — and whether the Street's post-gap upgrades generate enough new demand to keep the stock above the now-lagging mean price target.
See the live data behind this article on ORTEX.
Open AKAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
